ABL-101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABL-101, covering 2018-08-02 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Precision of ABL-101 Perfluorocarbon and Fluorine-19 MRI for the Mapping of Atherosclerotic Plaque Composition and Inflammation in Patients Undergoing Carotid Endarterectomy [Phase 2]